Search by Drug Name or NDC

    NDC 61314-0531-64 HYRIMOZ Details

    HYRIMOZ

    HYRIMOZ is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is .

    Product Information

    NDC 61314-0531
    Product ID 61314-531_5f7d6cf0-6300-4c73-a848-e9da6adf1680
    Associated GPIs
    GCN Sequence Number 084555
    GCN Sequence Number Description adalimumab-adaz SYRINGE 80 MG-40MG SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 53891
    HICL Sequence Number 045444
    HICL Sequence Number Description ADALIMUMAB-ADAZ
    Brand/Generic Brand
    Proprietary Name HYRIMOZ
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-adaz
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Sandoz Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761071
    Listing Certified Through 2024-12-31

    Package

    NDC 61314-0531-64 (61314053164)

    NDC Package Code 61314-531-64
    Billing NDC 61314053164
    Package 2 KIT in 1 CARTON (61314-531-64) / 1 KIT in 1 KIT * 1 SYRINGE, GLASS in 1 CARTON / .8 mL in 1 SYRINGE, GLASS * 1 SYRINGE, GLASS in 1 CARTON / .4 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-07-01
    NDC Exclude Flag N
    Pricing Information N/A